The use of inhaled corticosteroids in chronically ventilated preterm infants

Leif D. Nelin, J. Wells Logan

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Bronchopulmonary dysplasia (BPD) is the most usual reason for preterm infants to require chronic mechanical ventilation. Inflammation is a key factor underlying the lung injury leading to the development of BPD, and the rationale for use of corticosteroids in the management of ventilator-dependent preterm infants is based on their anti-inflammatory effects. Because systemic corticosteroids are associated with significant adverse effects in preterm infants, attention has turned to the use of inhaled corticosteroids (ICS) as a potentially safer therapy for BPD. The aim of this review is to discuss what is known about the efficacy and safety of ICS in chronically ventilated preterm infants. However, this has been a challenge since there is a paucity of high-grade evidence for the use of ICS in these patients. Thus, there is a real need for well-powered randomized controlled trials examining short- and long-term outcomes of ICS use in this population.

Original languageEnglish (US)
Pages (from-to)296-301
Number of pages6
JournalSeminars in Fetal and Neonatal Medicine
Volume22
Issue number5
DOIs
StatePublished - Oct 1 2017

Fingerprint

Premature Infants
Adrenal Cortex Hormones
Bronchopulmonary Dysplasia
Lung Injury
Mechanical Ventilators
Artificial Respiration
Anti-Inflammatory Agents
Randomized Controlled Trials
Inflammation
Safety
Population

Keywords

  • Bronchopulmonary dysplasia
  • Mechanical ventilation
  • Neonatal intensive care
  • Prematurity
  • Pulmonary function

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

The use of inhaled corticosteroids in chronically ventilated preterm infants. / Nelin, Leif D.; Logan, J. Wells.

In: Seminars in Fetal and Neonatal Medicine, Vol. 22, No. 5, 01.10.2017, p. 296-301.

Research output: Contribution to journalReview article

Nelin, Leif D. ; Logan, J. Wells. / The use of inhaled corticosteroids in chronically ventilated preterm infants. In: Seminars in Fetal and Neonatal Medicine. 2017 ; Vol. 22, No. 5. pp. 296-301.
@article{f1dac79f403047e785b59bc6bf1d27ef,
title = "The use of inhaled corticosteroids in chronically ventilated preterm infants",
abstract = "Bronchopulmonary dysplasia (BPD) is the most usual reason for preterm infants to require chronic mechanical ventilation. Inflammation is a key factor underlying the lung injury leading to the development of BPD, and the rationale for use of corticosteroids in the management of ventilator-dependent preterm infants is based on their anti-inflammatory effects. Because systemic corticosteroids are associated with significant adverse effects in preterm infants, attention has turned to the use of inhaled corticosteroids (ICS) as a potentially safer therapy for BPD. The aim of this review is to discuss what is known about the efficacy and safety of ICS in chronically ventilated preterm infants. However, this has been a challenge since there is a paucity of high-grade evidence for the use of ICS in these patients. Thus, there is a real need for well-powered randomized controlled trials examining short- and long-term outcomes of ICS use in this population.",
keywords = "Bronchopulmonary dysplasia, Mechanical ventilation, Neonatal intensive care, Prematurity, Pulmonary function",
author = "Nelin, {Leif D.} and Logan, {J. Wells}",
year = "2017",
month = "10",
day = "1",
doi = "10.1016/j.siny.2017.07.005",
language = "English (US)",
volume = "22",
pages = "296--301",
journal = "Seminars in Fetal and Neonatal Medicine",
issn = "1744-165X",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - The use of inhaled corticosteroids in chronically ventilated preterm infants

AU - Nelin, Leif D.

AU - Logan, J. Wells

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Bronchopulmonary dysplasia (BPD) is the most usual reason for preterm infants to require chronic mechanical ventilation. Inflammation is a key factor underlying the lung injury leading to the development of BPD, and the rationale for use of corticosteroids in the management of ventilator-dependent preterm infants is based on their anti-inflammatory effects. Because systemic corticosteroids are associated with significant adverse effects in preterm infants, attention has turned to the use of inhaled corticosteroids (ICS) as a potentially safer therapy for BPD. The aim of this review is to discuss what is known about the efficacy and safety of ICS in chronically ventilated preterm infants. However, this has been a challenge since there is a paucity of high-grade evidence for the use of ICS in these patients. Thus, there is a real need for well-powered randomized controlled trials examining short- and long-term outcomes of ICS use in this population.

AB - Bronchopulmonary dysplasia (BPD) is the most usual reason for preterm infants to require chronic mechanical ventilation. Inflammation is a key factor underlying the lung injury leading to the development of BPD, and the rationale for use of corticosteroids in the management of ventilator-dependent preterm infants is based on their anti-inflammatory effects. Because systemic corticosteroids are associated with significant adverse effects in preterm infants, attention has turned to the use of inhaled corticosteroids (ICS) as a potentially safer therapy for BPD. The aim of this review is to discuss what is known about the efficacy and safety of ICS in chronically ventilated preterm infants. However, this has been a challenge since there is a paucity of high-grade evidence for the use of ICS in these patients. Thus, there is a real need for well-powered randomized controlled trials examining short- and long-term outcomes of ICS use in this population.

KW - Bronchopulmonary dysplasia

KW - Mechanical ventilation

KW - Neonatal intensive care

KW - Prematurity

KW - Pulmonary function

UR - http://www.scopus.com/inward/record.url?scp=85026406288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026406288&partnerID=8YFLogxK

U2 - 10.1016/j.siny.2017.07.005

DO - 10.1016/j.siny.2017.07.005

M3 - Review article

C2 - 28768578

AN - SCOPUS:85026406288

VL - 22

SP - 296

EP - 301

JO - Seminars in Fetal and Neonatal Medicine

JF - Seminars in Fetal and Neonatal Medicine

SN - 1744-165X

IS - 5

ER -